Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
We aimed to determine if metformin use in both diabetic and non diabetic patients with sepsis and septic shock affects 28 day mortality and its effect on inflammatory markers. Plasma rennin, serum lactate concentration and IL6 will be measured for predicting 28 days in-hospital mortality in patients with sepsis.
Epistemonikos ID: d021e8cef9136ba401c86e2ea398249fdcf2672d
First added on: May 14, 2024